Talon Therapeuticsincis A Biopharmaceutical Company Dedicated To Seizing Upon Medical Opportunitiesefficiently And Expertly Leading Product Candidates Through Clinical Developmentand Transferring Value To Patientspatient Care Providersshareholderscorporate Partnersand Employees In Addition To Marqiboa Vinccristine Sulfate Liposome Injectionwhich Received Accelerated Approval From The Us Fda For The Treatment Of Philadelphia Chromosome Negative Adult Acute Lymphoblastic Leukemiaallpatients In Second Or Greater Relapse Or Whose Disease Has Progressed Following Two Or More Prior Lines Of Anti Leukemia Therapytalon Has Additional Pipeline Opportunities Some Of Which Like Marqibohave The Potential To Improve Delivery And Enhance The Therapeutic Benefits Of Well Characterizedproven Chemotherapies And Enable High Potency Dosing Without Increased Toxicity
